
Congenital Heart Disease Screening Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
5. Link Between Diabetes, Cardiovascular Disease Guide Current Clinical Trials
Patients with diabetes are significantly more likely to develop cardiovascular disease than nondiabetic patients.
Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention.
3. Once-Weekly Semaglutide Approved for Type 2 Diabetes
The FDA issued approval to semaglutide injection (Ozempic) for type 2 diabetes.
Targeting specific transportation system across the damaged blood-brain barrier could halt MS disease progression.
Pulse oximetry found to reduce infant death from congenital heart disease by 33%.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































